Literature DB >> 19065002

In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse model.

J Griffitts1, Y Tesiram, G E Reid, D Saunders, R A Floyd, R A Towner.   

Abstract

Current detection methods (computed tomography, ultrasound, and MRI) for hepatocarcinogenesis in humans rely on visual confirmation of neoplastic formations. A more effective early detection method is needed. Using in vivo magnetic resonance spectroscopy (MRS), we show that alterations in the integral ratios of the bis-allyl to vinyl hydrogen protons in unsaturated lipid fatty acyl groups correlate with the development of neoplastic formations in vivo in a TGFalpha/c-myc mouse hepatocellular carcinoma (HCC) model. HPLC analysis of the TGFalpha/c-myc mice liver tissue revealed a significant increase in the amount of oleic acid, along with alterations in linoleic and gamma-linolenic acids, as compared with control CD1 mice. Electrospray ionization tandem mass spectrometry analysis indicated a significant increase in the abundance of specific glycerol phosphatidylcholine (GPCho) lipids containing palmitic and oleic acids between control CD1 and TGFalpha/c-myc mice liver tissue extracts. Western blot analysis of the mice liver tissue indicates alterations in the desaturase enzyme stearoyl CoA desaturase (SCD)1, responsible for palmitic and oleic acid formation. Microarray analysis detected alterations in several genes involved with fatty acid metabolism, particularly SCD2, in transgenic mouse liver tissue. In correlation with the HPLC, mass spectrometry, Western blot, and microarray analyses, we are able to confirm the ability of in vivo MRS to detect precancerous lesions in the mouse liver before visual neoplastic formations were detectable by MRI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19065002      PMCID: PMC2656654          DOI: 10.1194/jlr.M800265-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  29 in total

1.  Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.

Authors:  Yasushi Kaji; Akihiko Wada; Izumi Imaoka; Michimasa Matsuo; Toshiro Terachi; Yoichiro Kobashi; Kazuro Sugimura; Masahiko Fujii; Katsuya Maruyama; Osamu Takizawa
Journal:  J Magn Reson Imaging       Date:  2002-12       Impact factor: 4.813

Review 2.  Polyunsaturated fatty acid regulation of gene expression.

Authors:  J M Ntambi; H Bené
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

3.  Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.

Authors:  W C A Gelderblom; W Moritz; S Swanevelder; C M Smuts; S Abel
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

4.  Quantitative study of the growth of experimental hepatic tumors in rats by using magnetic resonance imaging.

Authors:  Y Qin; M Van Cauteren; M Osteaux; G Willems
Journal:  Int J Cancer       Date:  1992-06-19       Impact factor: 7.396

5.  Selective killing of human cancer cells by polyunsaturated fatty acids.

Authors:  M E Bégin; U N Das; G Ells; D F Horrobin
Journal:  Prostaglandins Leukot Med       Date:  1985-08

6.  Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.

Authors:  H Murakami; N D Sanderson; P Nagy; P A Marino; G Merlino; S S Thorgeirsson
Journal:  Cancer Res       Date:  1993-04-15       Impact factor: 12.701

Review 7.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

8.  In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.

Authors:  Patrick J Bolan; Sina Meisamy; Eva H Baker; Joseph Lin; Timothy Emory; Michael Nelson; Lenore I Everson; Douglas Yee; Michael Garwood
Journal:  Magn Reson Med       Date:  2003-12       Impact factor: 4.668

9.  A random variance model for detection of differential gene expression in small microarray experiments.

Authors:  George W Wright; Richard M Simon
Journal:  Bioinformatics       Date:  2003-12-12       Impact factor: 6.937

View more
  11 in total

1.  In vivo NMR detection of diet-induced changes in adipose tissue composition.

Authors:  Rosa T Branca; Warren S Warren
Journal:  J Lipid Res       Date:  2011-01-26       Impact factor: 5.922

2.  Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy.

Authors:  Qiong Ye; Carsten Friedrich Danzer; Alexander Fuchs; Christian Wolfrum; Markus Rudin
Journal:  MAGMA       Date:  2012-03-23       Impact factor: 2.310

3.  Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model: Omega-3 fatty acids prevent liver neoplasia.

Authors:  J Griffitts; D Saunders; Y A Tesiram; G E Reid; A Salih; S Liu; T A Lydic; J V Busik; J X Kang; R A Towner
Journal:  Biochim Biophys Acta       Date:  2010-07-08

4.  Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Lahousse; Hu-Hua Hong; Tai-Vu Ton; Tiwanda Masinde; Scott S Auerbach; Kevin Gerrish; Pierre R Bushel; Keith R Shockley; Shyamal D Peddada; Robert C Sills
Journal:  Toxicol Pathol       Date:  2011-05-13       Impact factor: 1.902

5.  Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.

Authors:  Jyoti Srivastava; Ayesha Siddiq; Luni Emdad; Prasanna Kumar Santhekadur; Dong Chen; Rachel Gredler; Xue-Ning Shen; Chadia L Robertson; Catherine I Dumur; Phillip B Hylemon; Nitai D Mukhopadhyay; Deepak Bhere; Khalid Shah; Rushdy Ahmad; Shah Giashuddin; Jillian Stafflinger; Mark A Subler; Jolene J Windle; Paul B Fisher; Devanand Sarkar
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

Review 6.  High-field small animal magnetic resonance oncology studies.

Authors:  Louisa Bokacheva; Ellen Ackerstaff; H Carl LeKaye; Kristen Zakian; Jason A Koutcher
Journal:  Phys Med Biol       Date:  2013-12-30       Impact factor: 3.609

7.  Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.

Authors:  Huedayi Korkusuz; Lea Knau; Wolfgang Kromen; Frank Huebner; Renate Hammerstingl; Sebastian Lindemayr; Verena Bihrer; Albrecht Piiper; Thomas J Vogl
Journal:  Cancer Imaging       Date:  2012-03-07       Impact factor: 3.909

8.  Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells.

Authors:  Mélaine Minville-Walz; Anne-Sophie Pierre; Laurent Pichon; Sandrine Bellenger; Cécile Fèvre; Jérôme Bellenger; Christian Tessier; Michel Narce; Mickaël Rialland
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

9.  OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Chase A Brown; Xue Cai; Jadith Ziegler; Samantha Mallory; Mikhail G Dozmorov; Patricia Coutinho De Souza; Graham Wiley; Kyeongsoon Kim; Shinwook Kang; Doo-Sik Kong; Young-Tae Kim; Kar-Ming Fung; Jonathan D Wren; James Battiste
Journal:  Transl Oncol       Date:  2018-11-20       Impact factor: 4.243

10.  Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection.

Authors:  Jadegoud Yaligar; Wei Wei Teoh; Rashidah Othman; Sanjay Kumar Verma; Beng Hooi Phang; Swee Shean Lee; Who Whong Wang; Han Chong Toh; Venkatesh Gopalan; Kanaga Sabapathy; S Sendhil Velan
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.